Aparicio A, Eads CA, Leong L, Laird P, Newman EM, Synold TW, Baker S, Zhou M, Weber J. Phase I trial of continuous infusion 5-Aza-2'-Deoxycytidine. Cancer Chemother Pharmacol; 2003; 51: 231-239.
Blair SL, Grant M, Chu DZ, Cullinane C, Dean G, Schwarz RE, Wagman L. Quality of life in patients with colorectal, metastasis and intrahepatic chemotherapy. Annals of Surgical Oncology; 2003, 10(2): 144-149.
Borneman T, Chu DZ, Wagman LD, Ferrell BR, Juarez G, McCahill LE, Uman G. Concerns of family caregivers of patients with cancer facing palliative surgery for advanced malignancies. Oncology Nursing Forum; 2003, 30(6): 997-1005.
Castagnetta LA, Agostara B, Montalto G, Polito L, Campisi I, Saetta A, Itoh T, Yu B, Chen S, Carruba G. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells. Cancer Research; 2003, 63(16): 5041-5045.
Chen SA, Zhang FM, Sherman MA, Kijima I, Cho M, Yuan YC, Toma Y, Osawa Y, Zhou DJ, Eng ET. Structure-function studies of aromatase and its inhibitors: a progress report. Journal of Steroid Biochemistry and Molecular Biology; 2003, 86(3-5): 231-237.
Cheung SY, Yuen MT, Choi HL, Cheng HK, Huang Y, Chen S, Chan FL. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats. International Journal of Oncology; 2003, 22(6): 1383-1395.
Clark JI, Atkins MB, Urba WJ, Creech S, Figlin RA, Dutcher JP, Flaherty L, Sosman JA, Logan TF, White R, Weiss GR, Redman BG, Tretter CP, McDermott D, Smith JW, Gordon MS, Margolin KA. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: A cytokine working group randomized trial. Journal of Clinical Oncology; 2003, 21(16): 3133-3140.
Cullinane CA, Borneman T, Smith DD, Chu DZ, Ferrell BR, Wagman LD. The surgical treatment of cancer - A comparison of resource utilization following procedures performed with curative and palliative intent. Cancer; 2003, 98(10): 2266-2273.
Daftarian P, Ali S, Sharan R, Lacey SF, La RC, Longmate J, Buck C, Siliciano RF, Diamond DJ. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge. Journal of Immunology; 2003, 171(8): 4028-4039.
Eng ET, Ye JJ, Williams D, Phung S, Moore RE, Young MK, Gruntmanis U, Braunstein G, Chen S. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Research; 2003, 63(23): 8516-8522.
Espenschied J, Lamont J, Longmate J, Pendas S, Wang Z, Diamond DJ, Ellenhorn JD. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model. J Immunol; 2003, 170(6): 3401-7.
Esworthy RS, Binder SW, Doroshow JH, Chu FF. Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression. Biol Chem; 2003, 384(4): 597-607.
Ferrell BR, Chu DZ, Wagman L, Juarez G, Borneman T, Cullinane C, McCahill LE. Patient and surgeon decision-making regarding surgery of advanced malignancies. Oncology Nursing Forum; 2003, 30(6): E106-E114.
Fuller RA, Clark J, Kretzner L, Korns D, Blair SL, Crocitto LE, Smith SS. Use of microfluidics chips for the detection of human telomerase RNA. Analytical Biochemistry; 2003, 313(2): 331-334.
Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O'Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. Biology of Blood and Marrow Transplantation; 2003, 9(10): 649-656.
Fung HC, Stein F, Slovak ML, O'Donnell MR, Snyder DS, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E, Forman SJ. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: Impact of cytogenetic characteristics on transplantation outcome. Biology of Blood and Marrow Transplantation; 2003, 9(12): 766-771.
Juhasz A, Frankel P, Cheng C, Rivera H, Vishwanath R, Chiu A, Margolin K, Yen Y, Newman EM, Synold T, Wilczynski S, Lenz HJ, Gandara D, Albain KS, Longmate J, Doroshow JH. Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products. J Clin Lab Anal; 2003, 17(5): 184-94.
Kakuda JT, Wagman L. 86. Impact of multiple surgical procedures on liver control in patients with metastases from colorectal cancer. Jour of Gastrointestinal Surgery; 2003, 7(2): 284-5.
Kinoshita Y, Chen S. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Res; 2003, 63(13): 3546-55.
Lara PN, Frankel P, Mack PC, Gumerlock PH, Galvin I, Martel CL, Longmate J, Doroshow JH, Lenz HJ, Lau DH, Gandara DR. Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: A California Cancer Consortium phase I and molecular correlative study. Clinical Cancer Research; 2003, 9(12): 4356-4362.
Lara PN, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR. SU5416 plus interferon alpha in advanced renal cell carcinoma: A phase II California cancer consortium study with biological and imaging correlates of angiogenesis inhibition. Clinical Cancer Research; 2003, 9(13): 4772-4781.
Linker C, Anderlini P, Herzig R, Christiansen N, Somlo G, Bensinger W, Fay J, Lynch JP, Goodnough LT, Ashby M, Benyunes MC, Jones DV, Yang TA, Miller LL, Weaver C. Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation. Biology of Blood and Marrow Transplantation; 2003, 9(6): 405-413.
Maloney DG, Molina AJ, Sahebi F, Stockerl GK, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood; 2003, 102(9): 3447-3454.
Margolin K. High dose chemotherapy and stem cell support in the treatment of germ cell cancer. J Urol; 2003, 169(4): 1229-33.
Morgan RJ, Doroshow JH, Synold T, Lim D, Shibata S, Margolin K, Schwarz R, Leong L, Somlo G, Twardowski P, Yen Y, Chow W, Lin P, Paz B, Chu D, Frankel P, Stalter S. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: Dose-limiting toxicity and pharmacokinetics. Clinical Cancer Research; 2003, 9(16): 5896-5901.
Morgan RJ, Newman EM, Sowers L, Scanlon K, Harrison J, Akman S, Leong L, Margolin K, Niland J, Raschko J, Somlo G, Carroll M, Chow W, Tetef M, Hamasaki V, Yen Y, Doroshow JH. Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies. Cancer Chemother Pharmacol; 2003, 51(6): 459-464.
Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M, Xiao J, Han T, Zhu Z, Wang T, Liu X, Lopez R, Frankel P, Jong A, Yen Y. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol; 2003, 162(6): 1961-74.
Schwarz RE, Smith DD, Keny H, Ikle DN, Shibata SI, Chu DZ, Pezner RD. Impact of intraoperative radiation on postoperative and disease- specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysis. Am J Clin Oncol; 2003, 26(1): 16-21.
Sommer SS, Jiang ZF, Feng JM, Buzin CH, Zheng J, Longmate J, Jung M, Moulds J, Dritschilo A. ATM missense mutations are frequent in patients with breast cancer. Cancer Genetics and Cytogenetics; 2003, 145(2): 115-120.
Sprauten PF, Beringer PM, Louie SG, Synold TW, Gill MA. Stability and antibacterial activity of cefepime during continuous infusion. Antimicrobial Agents and Chemotherapy; 2003, 47(6): 1991-1994.
Stein AS, Nademanee A, O'Donnell MR, Lee J, Schmidt GM, Parker PM, Snyder DS, Smith EP, Somlo G, Margolin KA, Fahey J, Niland JC, Forman SJ. High dose cytosine arabinoside and daunorubicin induction therapy for acute myelogenous leukemia - results for 100 consecutive treated patients and analysis of adverse prognostic factors impact on achieving a remission. Leukemia; 2003; 14: 1191-6.
Stein AS, O'Donnell MR, Slovak ML, Snyder DS, Nademanee AP, Parker P, Molina A, Somlo G, Fung HC, Krishnan A, Rodriguez R, Spielberger RT, Wang S, Dagis A, Vora N, Arber DA, Niland JC, Forman SJ. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol; 2003, 21(4): 615-23.
Suetsugi M, Su LL, Karlsberg K, Yuan YC, Chen S. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Molecular Cancer Research; 2003, 1(13): 981-991.
Ten TA, Synold TW, Spicer D, Verweij J, Doroshow JH, Sparreboom A. Effect of valspodar on the pharmacokinetics of unbound paclitaxel. Investigational New Drugs; 2003, 21(3): 291-298.
Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA. A phase I trial of Y-90-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer. Clinical Cancer Research; 2003, 9(16): 5842-5852.
Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res; 2003, 63(5): 980-6.
Yen Y. Ribonucleotide reductase subunit one as gene therapy target. Clinical Cancer Research; 2003, 9(12): 4304-4308.
Zhou BS, Liu XY, Mo XL, Xue LJ, Darwish D, Qiu WH, Shih J, Hwu EB, Luh F, Yen Y. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53. Cancer Research; 2003, 63(20): 6583-6594.
Schwarz RE, Donohue CA, Sadava D, Kane SE. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment. Cancer Letters; 2003, 189(1): 59-68.
Wong JY, Chu D, Williams LE, Yamauchi DM, Ikle D, Wilczynski S, Colcher D, Yazaki P, Shively J, Wu A, Raubitschek A. Tumor imaging with a I-123-labeled 80 kD engineered anti-CEA antibody fragment (cT84.66 minibody) in patients with colorectal cancer. Journal of Nuclear Medicine; 2003, 44(5): 402P-402P.
Knox RJ, Burke PJ, Chen S, Kerr DJ. CB 1954: From the Walker tumor to NQO2 and VDEPT. Current Pharmaceutical Design; 2003, 9(26): 2091-2104.
Cheng JJ, Khin KT, Jensen GS, Liu AJ, Davis ME. Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates. Bioconjugate Chemistry; 2003, 14(5): 1007-1017.
Popielarski SR, Mishra S, Davis ME. Structural effects of carbohydrate-containing polycations on gene delivery. 3. Cyclodextrin type and functionalization. Bioconjugate Chemistry; 2003, 14(3): 672-678.
Reineke TM, Davis ME. Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centers. Bioconjugate Chemistry; 2003, 14(1): 247-254.
Reineke TM, Davis ME. Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center type. Bioconjugate Chemistry; 2003, 14(1): 255-261.
Chu DZ, Chansky K, Alberts DS, Meyskens FL, Fenoglio PC, Rivkin SE, Mills GM, Giguere JK, Goodman GE, Abbruzzese JL, Lippman SM. Adenoma recurrences after resection of colorectal carcinoma: Results from the southwest oncology group 9041 calcium - Chemoprevention pilot study. Annals of Surgical Oncology; 2003, 10(8): 870-875.
Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. New England Journal of Medicine; 2003, 348(8): 694-701.
McCahill LE, Smith DD, Borneman T, Juarez G, Cullinane C, Chu DZ, Ferrell BR, Wagman LD. A prospective evaluation of palliative outcomes for surgery of advanced malignancies. Annals of Surgical Oncology; 2003, 10(6): 654-663.
Shamberger RC, LaQuaglia MP, Gebhardt MC, Neff JR, Tarbell NJ, Marcus KC, Sailer SL, Womer RB, Miser JS, Dickman PS, Perlman EJ, Devidas M, Linda SB, Krailo MD, Grier HE, Granowetter L. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall - Impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Annals of Surgery; 2003, 238(4): 563-567.
Takimoto CH, Remick SC, Sharma S, Mani S, Ramanathan RK, Doroshow J, Hamilton A, Mulkerin D, Graham M, Lockwood GF, Ivy P, Egorin M, Schuler B, Greenslade D, Goetz A, Knight R, Thomas R, Monahan BP, Dahut W, Grem JL. Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: A National Cancer Institute Organ Dysfunction Working Group Study. Journal of Clinical Oncology; 2003, 21(14): 2664-2672.
